Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Paul Sargos, Sylvie Chabaud, I. Latorzeff, +14

The Lancet Oncology

Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine +6

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

C. Carrié, Nicolas Magné, Patricia Burban-Provost, +19

The Lancet Oncology

Surgical OncologyUrologyRadiation TherapyGenitourinary CancerMedicine +6

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

Sylvie Bonvalot, C. Le Péchoux, Thierry de Baère, +13

Clinical Cancer Research

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

M. Savina, Axel Le Cesne, Jean‐Yves Blay, +16

BMC Medicine

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, +117

European Urology

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Alan Horwich, Marek Babjuk, Joaquim Bellmunt, +118

Annals of Oncology

UrologyGenitourinary CancerEau–esmo Consensus StatementsMedicineCancer Management +5

Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus

Thomas Zilli, Vérane Achard, Alan Dal Pra, +22

Radiotherapy and Oncology

Brain Metastases from Thyroid Carcinoma: A Retrospective Study of 21 Patients

Bénédicte Henriques de Figueiredo, Yann Godbert, Isabelle Soubeyran, +8

Thyroid

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer

S. Supiot, Loïg Vaugier, Xavier Buthaud, +14

European Urology

UrologyMedicinePharmacotherapyHormone TherapyOligopelvis Getug P07 +4

Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, +16

The Lancet

Factorial DesignUrologyRadiation Medicine× 2Radiation Therapy +7